IP Library Granted Patent US 8,641,738
Granted Patent B1
US 8,641,738 · App. 13/357,800 · Granted Feb 4, 2014

Method of treating scoliosis using a biological implant

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,641,738
App. No.
13/357,800
Granted
Feb 4, 2014
Kind
B1
Abstract

The present invention is a bone growth stimulating and promoting cytokine type biological implant preferably comprising PTH coated with a controlled release biodegradable coating that is implanted preferably in the concave side of a scoliotically curved spine in combination with a bone growth inhibiting type biological implant preferably comprising methotrexate or like anti-metabolite coated with a controlled release biodegradable coating that is implanted preferably in the convex side of a scoliotically curved spine. The insertion of the biological implant is highly non-invasion, especially as compared to more conventional spine surgical methods, and the biological implant does not decrease spinal mobility or spinal range of motion.

Claims (7)

1. A method for use in treating scoliosis in a vertebrate patient, said method comprising selecting at least one of a patient at risk of spine curve progression based on at least one AIS curve progression associated biological marker determined to be present in the DNA of said patient and a patient not at risk of spine curve progression based on at least one AIS curve non-progression associated biological marker determined to be present in the DNA of said patient, and applying at least one of a spine curve progression therapeutic to said patient at risk of spine curve progression and a spine curve non-progression therapeutic to said patient not at risk of spine curve progression.

2. The method of claim 1 , wherein said spine curve progression at-risk therapeutic defines at least one of implanting a biological implant into said patient, performing spinal surgery on said patient, applying a brace to said patient, continuing the use of a brace on said patient, taking a spinal X-ray of said patient, continuing ongoing periodic spinal X-rays of said patient, and monitoring spine curve progression of said patient, and wherein said spine curve progression non-risk therapeutic defines at least one of the cancelation of a contemplated implantation of a biological implant into said patient, the cancelation of contemplated spinal surgery of said patient, the prevention of the application of a brace to said patient, the cancelation of continued use of a brace on said patient, the prevention of the taking of a spinal X-ray of said patient, the cancelation of ongoing periodic spinal X-rays of said patient, and the cancelation of monitoring of spine curve progression of said patient.

3. The method of claim 2 , wherein said biological implant defines a dissolvable bone growth stimulant coated with a dissolvable coating.

4. The method of claim 2 , wherein said biological implant comprises an implant of at least one of a Parathyroid hormone, a Fibroblast growth factor, an androgen, an Insulin-like Growth Factor, an Estrogen, a Transforming Growth Factor, and an inorganic phosphate.

5. The method of claim 2 , wherein said biological implant defines at least one bone growth promoting implant and at least one bone growth inhibiting implant, and wherein said spine includes a curve formed therein, and wherein said at least one bone growth promoting implant is inserted proximate a concave side of said curve of said spine, and wherein said at least one bone growth inhibiting implant is inserted proximate a convex side of said curve of said spine.

6. The method of claim 2 , wherein said spinal surgery defines joining at least one mechanical implant to a first vertebra and to a second vertebra of the spine of said patient.

7. The method of claim 2 , wherein said brace defines an external brace for scoliosis therapy comprising: a rod having a first end and a second end; an auxiliary pad connected to said rod proximate said first end of said rod; a pelvic mold connected to said rod proximate said second end of said rod; a mechanical adjustment mechanism coupled to said rod between said first end of said rod and said second end of said rod, and an apical pad connected to said adjustment mechanism.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 23, 2018
From: SCHRAMM, MICHAEL R.
To: PREDICTIVE TECHNOLOGY GROUP, INC.
Reel/Frame 044699/0501 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 19, 2018
From: SCHRAMM, MICHAEL R.
To: PREDICTIVE THERAPEUTICS, LLC
Reel/Frame 044666/0421 →
LIEN Recorded Dec 9, 2016
From: TRANSGENOMIC, INC.
To: SCHWEGMAN, LUNDBERG & WOESSNER, P.A.
Reel/Frame 040898/0083 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 12, 2013
From: AXIAL BIOTECH, INC.
To: SCHRAMM, MICHAEL R.
Reel/Frame 031003/0677 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 25, 2012
From: OGILVIE, JAMES W.; WARD, KENNETH; NELSON, LESA M.
To: AXIAL BIOTECH, INC.
Reel/Frame 027590/0863 →